hotspot -WSS

hotspot

author：focus 2025-09-14 21:55:02 - browse：31632

NEW ORLEANS — For some patients suffering with certain blood cancers, CAR-T therapy can offer the tantalizing chance to end their disease with a single treatment.

But the immunotherapy takes time to manufacture, and patients often have to wait weeks to actually receive an infusion once they’re eligible. For some patients with especially aggressive cancer, they can die while waiting for the therapy to arrive.

That’s spurred CAR-T manufacturers to find ways to speed up manufacturing. The industry is testing newer — and possibly better — CAR-T cells that can be made more quickly. Researchers working with Novartis presented Phase 1 clinical trial data Sunday on a new CAR-T cell made with a rapid manufacturing process at the annual American Society of Hematology meeting.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Walensky prepares to leave CDC — and Congress — behind
Next article： Readers respond to H5N1 and livestock movements, and more

entertainment

WSS

Readout LOUD podcast: A CRISPR milestone, biotech mixology

A daunting task: navigating dual Medicare, Medicaid eligibility

Readout Newsletter: The latest at Gilead, Catalent, and the NIH

NYU radiologists take on the challenge of expensive MRI machines

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Gain of function research would be limited under House proposal

Wikipedia

hotspot

entertainment

Peter Hotez and the public health issue of online harassment

Surge of respiratory disease in China has likely explanation

George Santos makes 1st court appearance after pleading not guilty to 13 counts

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Apple is now the first public company to be valued at $3 trillion

Weight loss drug Wegovy cuts risk of heart attacks in milestone trial

Tori Bowie and the unacceptable rates of Black maternal death

David Sabatini, ex

In age of alternative facts, a scholarly course on calling out crap

NYU radiologists take on the challenge of expensive MRI machines

hotspot

Astellas still sees hope in its gene therapy after four deaths

U.K. considers world's first use of meningitis vaccine to address gonorrhea

Astellas still sees hope in its gene therapy after four deaths

PBM reforms clear House panel

Anxious about a speech? A startup wants you to pop a minty cardiac drug

Congress must reauthorize a committee to support older Americans

hotspot

hotspot

entertainment

entertainment